Spots Global Cancer Trial Database for Efficacy and Safety Study of ABP 980 Compared With Trastuzumab in Women With HER2-positive Early Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Efficacy and Safety Study of ABP 980 Compared With Trastuzumab in Women With HER2-positive Early Breast Cancer
Official Title: A Randomized, Double-Blind, Phase 3 Study Evaluating the Efficacy and Safety of ABP 980 Compared With Trastuzumab in Subjects With HER2 Positive Early Breast Cancer
Study ID: NCT01901146
Conditions
Study Description
Brief Summary: The purpose of this research study is to compare the effectiveness and safety of ABP 980 against trastuzumab in women with human epidermal growth factor receptor 2 (HER2)-positive early breast cancer.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Research Site, Brest, , Belarus
Research Site, Grodno, , Belarus
Research Site, Minsk, , Belarus
Research Site, Minsk, , Belarus
Research Site, Salvador, Bahia, Brazil
Research Site, Ijuí, RIO Grande DO SUL, Brazil
Research Site, Porto Alegre, RIO Grande DO SUL, Brazil
Research Site, Jaú, SAO Paulo, Brazil
Research Site, Santo André, SAO Paulo, Brazil
Research Site, São Paulo, SAO Paulo, Brazil
Research Site, Sofia, Sofiya, Bulgaria
Research Site, Veliko Tarnovo, Veliko Turnovo, Bulgaria
Research Site, Pleven, , Bulgaria
Research Site, Varna, , Bulgaria
Research Site, Moncton, New Brunswick, Canada
Research Site, Montréal, Quebec, Canada
Research Site, Temuco, Cautín, Chile
Research Site, Santiago, , Chile
Research Site, Fürstenwalde, Brandenburg, Germany
Research Site, Frankfurt am Main, Hessen, Germany
Research Site, Frankfurt, Hessen, Germany
Research Site, Bonn, Nordrhein-westfalen, Germany
Research Site, Bottrop, Nordrhein-westfalen, Germany
Research Site, Berlin, , Germany
Research Site, Athens, Attica, Greece
Research Site, Athens, Attica, Greece
Research Site, Heraklion, Crete, Greece
Research Site, Thessaloniki, Nea Efkarpia, Greece
Research Site, Debrecen, Hajdu-bihar, Hungary
Research Site, Szolnok, Jasz-nagykun-szolnok, Hungary
Research Site, Nyíregyháza, Szabolcs-szatmar-bereg, Hungary
Research Site, Szekszárd, Tolna, Hungary
Research Site, Budapest, , Hungary
Research Site, Budapest, , Hungary
Research Site, San Fermo della Battaglia, Como, Italy
Research Site, Bari, , Italy
Research Site, Milano, , Italy
Research Site, Palermo, , Italy
Research Site, Parma, , Italy
Research Site, Piacenza, , Italy
Research Site, Varese, , Italy
Research Site, Monterrey, Nuevo LEON, Mexico
Research Site, San Luis Potosí, SAN LUIS Potosi, Mexico
Research Site, Queretaro, , Mexico
Research Site, Toluca, Estado De Mexico, , Mexico
Research Site, Bydgoszcz, Kujawsko-pomorskie, Poland
Research Site, Warszawa, Lubelskie, Poland
Research Site, Warszawa, Mazowieckie, Poland
Research Site, Warszawa, Mazowieckie, Poland
Research Site, Gdańsk, Pomorskie, Poland
Research Site, Rybnik, Slaskie, Poland
Research Site, Poznań, Wielkopolskie, Poland
Research Site, Poznań, Wielkopolskie, Poland
Research Site, Cluj-Napoca, Cluj, Romania
Research Site, Ploiesti, Prahova, Romania
Research Site, Timisoara, Timis, Romania
Research Site, Brasov, , Romania
Research Site, Cluj, , Romania
Research Site, Obninsk, Kaluzhskaya, Russian Federation
Research Site, Saransk, Mordovia, Russian Federation
Research Site, Moscow Region, Moscow, Russian Federation
Research Site, Arkhangelsk, Primorskiy, Russian Federation
Research Site, Yaroslavl, Yaroslavlr, Russian Federation
Research Site, Chelaybinsk, , Russian Federation
Research Site, Moscow, , Russian Federation
Research Site, Nizhny Novgorod, , Russian Federation
Research Site, Pyatigorsk, , Russian Federation
Research Site, Ryazan, , Russian Federation
Research Site, Saint Petersburg, , Russian Federation
Research Site, Saint Petersburg, , Russian Federation
Research Site, Saint-Petersburg, , Russian Federation
Research Site, Sochi, , Russian Federation
Research Site, Belgrade, , Serbia
Research Site, Belgrade, , Serbia
Research Site, Kragujevac, , Serbia
Research Site, Nis, , Serbia
Research Site, Sremska Kamenica, , Serbia
Research Site, Johannesburg, Gauteng, South Africa
Research Site, Durban, KwaZulu-Natal, South Africa
Research Site, Cape Town, Western Cape, South Africa
Research Site, Cape Town, Western Cape, South Africa
Research Site, Sabadell, Barcelona, Spain
Research Site, A Coruña, LA Coruna, Spain
Research Site, Lérida, Lleida, Spain
Research Site, Alcorcón, Madrid, Spain
Research Site, Barcelona, , Spain
Research Site, Madrid, , Spain
Research Site, Madrid, , Spain
Research Site, Kyiv, Kiev, Ukraine
Research Site, Uzhgorod, Transcarpathia, Ukraine
Research Site, Lutsk, Volyn, Ukraine
Research Site, Chernivtsi, , Ukraine
Research Site, Dnipropetrovsk, , Ukraine
Research Site, Kharkiv, , Ukraine
Research Site, Lviv, , Ukraine
Research Site, Zaporizhzhya, , Ukraine
Research Site, Nottingham, England, United Kingdom
Research Site, Peterborough, England, United Kingdom
Contact Details
Name: MD
Affiliation: Amgen
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
